|
|
|
| Application Value of NovaSure Impedance-controlled Endometrial Ablation in Treatment of Refractory Abnormal Uterine Bleeding |
| LI Xue-ying, LU Yan, Cui Cao-mei, et al |
| The Maternal and Child Health Hospital Of Hunan Province, Changsha, Hunan 410008 |
|
|
|
|
Abstract Objective To explore the value of NovaSuer impedance controlled endometrial ablation system in the treatment of refractory abnormal uterine bleeding (AUB). Methods A total of 68 patients with refractory AUB were treated with NovaSure impedance controlled endometrial ablation. General surgery procedure, complications curative effect and follow-up results were recorded. Results The surgery was successfully completed in all 68 cases. The NovaSure treatment time was 28~120 (mean 61.90±19.73) s. The intraoperative bleeding was less than 10 mL with no serious complications occurred during the operation. At postoperative 1 month, 3 months, 6 months, 12 months and 24 months, the effective rates of menstrual improvement were 100%(68/68),100%(68/68),98.53%(67/68),98.53%(67/68) and 97.30%(36/37), respectively. The rates of amenorrhea were 63.23%(43/68),63.23%(43/68),63.23%(43/68) ,63.23%(43/68) and 59.45%(22/37), respectively. At 3 months after operation, the postoperative hemoglobin was (103.12±7.74 g/L) ,which was higher than the preoperative hemoglobin (92.70±8.26 g/L). The difference was statistically significant (P<0.05). Conclusion NovaSure is safe and effective for the treatment of AUB. Surgery can even be performed in an outpatient clinic. NovaSure is especially suitable for refractory AUB patients with conservative treatment failure and severe medical diseases who cannot tolerant drugs and hysterectomy.
|
|
Received: 26 February 2018
|
|
|
|
|
|
[1] 熊小琴,石海燕,朱虹,等.子宫内膜部分电切术治疗难治性异常子宫出血38例分析[J].中国综合临床,2013,29(7):776.
[2] Kumar V, Chodankar R, Gupta JK.Endometrial ablation for heavy menstrual bleeding[J].Womens Health (Lond),2016,12(1):45-52.
[3] 范颖,张军,孙晓媛,等.诺舒治疗心脏病术后异常子宫出血15例报告[J].中国微创外科杂志,2015,15(1):54-58.
[4] 苏慧明, 徐燕, 黎颖雄,等.诺舒子宫内膜去除术治疗子宫腺肌病致月经过多的临床研究[J].中国计划生育和妇产科, 2014,6(3):41-43.
[5] 中华医学会妇产科分会妇科内分泌组,异常子宫出血诊断与治疗指南[J].中华妇产科杂志,2014,49(11):801-806.
[6] Li LI, Luo XP, Chen WF. Hysteroscopic appearance of the endometrial cavity after microwave endometrial ablation[J].J Minim Invasive Gynecol,2010, 17(1):30-36.
[7] 冯力民,边茜.诺舒阻抗控制子宫内膜切除术的临床应用现状[J].武警医学,2016,27(6):541-544.
[8] 石青,陈华,夏雪.诺舒子宫内膜去除术治疗异常子宫出血的临床研究[J].宁夏医学杂志,2016,38(9):836-838.
[9] 孙小丽,赵春梅,刘婷艳,等.宫腔镜在诺舒阻抗控制子宫内膜去除术后并发症中的诊治价值(附9例报告)[J].中国微创外科杂志,2015,15(8):723-725.
[10] 曾巧云.术前子宫内膜薄化在宫腔镜治疗功能失调性子宫出血的价值[J].中国医药导报,2011,8(25):36-37,39.
[11] Kalkat RK,Cartmill RS. NovaSure endometrial ablation under local anaesthesia in an outpatient setting:an observational study [J].J Obstet Gynaecol,2011,31(2)152-155.
[12] Van Riemsdijk VM, Graziosi GC, Veersema S,et al.Vaginal myoma expulsion after NovaSure endometrial ablation[J].J Minim Invasive Gynecol,2009,16(4):496-497.
[13] Yin CS.Pregnancy after hysteroscopic endometrial ablation without endometrial preparation:a report of five cases and a literature review[J].Taiwan J Obstet Gynecol,2010,49(3):311-319.
[14] Lybol C,van der Coelen S,Hamelink A,et al.Predictors of long-term novasure endometrial ablation failure[J].J Minim Invasive Gynecol,2018,25(7): 1255-1259.
[15] Sherif A. El-Nashar, MBBCh, MS,et al.Prediction of Treatment Outcomes After Global Endometrial Ablation[J].Obstet Gynecol,2009,113(1): 97-106.
[16] Philip CA,Le Mitouard M,Maillet L,et al.Evaluation of NovaSure global endometrial ablation in symptomatic adenomyosis: A longitudinal study with a 36 month follow-up[J].Eur J Obstet Gynecol Reprod Biol,2018, 227: 46-51. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(2): 309-313. |
|
|
|
|
2019, Vol. 36 
